Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 1.276
+0.078 (6.51%)
Nov 2, 2026, 4:15 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 408.95 million as of November 2, 2026. It is the 31,819th most valuable company in the world and the 425th biggest in Sweden. Its market cap has increased by 110.84% in one year.
Market Cap
408.95M
Enterprise Value
294.12M
Revenue
n/a
Global Rank
Country Rank
#425 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 408.95M, a decrease of -52.08%. That is a compound annual growth rate of -7.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 408.95M | 99.56% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |
| FluoGuide | 498.65M |
| Cantargia AB | 451.68M |
| Sprint Bioscience AB | 379.86M |
| Corline Biomedical AB | 371.09M |
| BioInvent International AB | 357.32M |
| Mendus AB | 352.63M |